Арилжаа iBio, Inc. - IBIO CFD

Арилжааны нөхцөл

• Төрөл: CFD
• Спред: 0.0260
• Лонг позицын шөнийн санхүүжилтийн тохируулга: -0.02157%
• Шорт позицын нэг шөнийн санхүүжилтийн тохируулга: -0.00065%
• Шөнийн санхүүжилтийг тохируулах хугацаа: 22:00 (UTC)
• Валют: USD
• Арилжаалсан доод хэмжээ: 10
• Маржин: 5.00%
• Хөрөнгийн бирж: United States of America
• Арилжааны шимтгэл: 0%
• Баталгаат стопын шимтгэл: 1%

Гол үзүүлэлтүүд

• Өмнөх Хаах: 2.147
• Нээх: 2.137
• 1 жилийн өөрчлөлт: -26.74%
• Өдрийн диапазон: 2.067 - 2.137

iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company''s services cover the stages of pre-clinical development, regulatory approval, commercial product launch, and on-going commercial phase requirements. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. The company is also developing vaccine candidates for third parties. It has a license agreement with the University of Natural Resources and Life Sciences, Vienna; a strategic relationship with Beijing CC-Pharming Ltd.; and collaboration agreements with AzarGen Biotechnologies (Pty) Ltd, The Texas A&M University System, and Fraunhofer Center for Molecular Biotechnology. In addition, the company offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.